Cargando…
Cell-based therapies for coronavirus disease 2019: proper clinical investigations are essential
The serious consequences of the global coronavirus disease 2019 (COVID-19) pandemic have prompted a rapid global response to develop effective therapies that can lessen disease severity in infected patients. Cell-based approaches, primarily using mesenchymal stromal cells (MSCs), have demonstrated a...
Autores principales: | Khoury, Maroun, Rocco, Patricia R.M., Phinney, Donald G., Krampera, Mauro, Martin, Ivan, Viswanathan, Sowmya, Nolta, Jan A., LeBlanc, Katarina, Galipeau, Jacques, Weiss, Daniel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163352/ https://www.ncbi.nlm.nih.gov/pubmed/32933835 http://dx.doi.org/10.1016/j.jcyt.2020.04.089 |
Ejemplares similares
-
An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells Committee editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for coronavirus disease-19: time for a global registry
por: Weiss, Daniel J., et al.
Publicado: (2022) -
Clinical Considerations During Breakthrough Coronavirus Disease 2019 Infections in Vaccinated Individuals With Autoimmunity
por: Rocco, Joseph M, et al.
Publicado: (2021) -
Hospitalized coronavirus disease-2019 (COVID-19) patients with gastrointestinal symptoms have improved survival to discharge
por: Renelus, Benjamin D., et al.
Publicado: (2020) -
Famotidine and Coronavirus Disease 2019
por: Freedberg, Daniel E., et al.
Publicado: (2021) -
The Proper Adoption and Use of Compound Titles
Publicado: (1893)